ArticleHemaSphere2022

High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis.

Elsemieke Te Linde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.